Cargando…
Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649387/ http://dx.doi.org/10.1186/2051-1426-3-S2-P186 |
_version_ | 1782401347437461504 |
---|---|
author | Grimaldi, Antonio Maria Simeone, Ester Festino, Lucia Giannarelli, Diana Palla, Marco Caracò, Corrado Curvietto, Marcello Esposito, Assunta Grimaldi, Maria Chiara Mozzillo, Nicola Ascierto, Paolo A |
author_facet | Grimaldi, Antonio Maria Simeone, Ester Festino, Lucia Giannarelli, Diana Palla, Marco Caracò, Corrado Curvietto, Marcello Esposito, Assunta Grimaldi, Maria Chiara Mozzillo, Nicola Ascierto, Paolo A |
author_sort | Grimaldi, Antonio Maria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4649387 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46493872015-11-24 Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients Grimaldi, Antonio Maria Simeone, Ester Festino, Lucia Giannarelli, Diana Palla, Marco Caracò, Corrado Curvietto, Marcello Esposito, Assunta Grimaldi, Maria Chiara Mozzillo, Nicola Ascierto, Paolo A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649387/ http://dx.doi.org/10.1186/2051-1426-3-S2-P186 Text en Copyright © 2015 Grimaldi et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Grimaldi, Antonio Maria Simeone, Ester Festino, Lucia Giannarelli, Diana Palla, Marco Caracò, Corrado Curvietto, Marcello Esposito, Assunta Grimaldi, Maria Chiara Mozzillo, Nicola Ascierto, Paolo A Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title | Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title_full | Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title_fullStr | Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title_full_unstemmed | Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title_short | Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
title_sort | correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649387/ http://dx.doi.org/10.1186/2051-1426-3-S2-P186 |
work_keys_str_mv | AT grimaldiantoniomaria correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT simeoneester correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT festinolucia correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT giannarellidiana correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT pallamarco correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT caracocorrado correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT curviettomarcello correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT espositoassunta correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT grimaldimariachiara correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT mozzillonicola correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients AT asciertopaoloa correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients |